Share Name Share Symbol Market Type Share ISIN Share Description
Renew Holdings Plc LSE:RNWH London Ordinary Share GB0005359004 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -5.00 -0.62% 805.00 186,247 16:20:22
Bid Price Offer Price High Price Low Price Open Price
804.00 814.00 812.00 780.00 812.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Construction & Materials 620.37 32.10 26.78 30.1 632
Last Trade Time Trade Type Trade Size Trade Price Currency
16:19:58 AT 100 805.00 GBX

Renew (RNWH) Latest News

More Renew News
Renew Investors    Renew Takeover Rumours

Renew (RNWH) Discussions and Chat

Renew (RNWH) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Renew trades in real-time

Renew (RNWH) Top Chat Posts

Renew Daily Update: Renew Holdings Plc is listed in the Construction & Materials sector of the London Stock Exchange with ticker RNWH. The last closing price for Renew was 810p.
Renew Holdings Plc has a 4 week average price of 748p and a 12 week average price of 673p.
The 1 year high share price is 875p while the 1 year low share price is currently 430p.
There are currently 78,555,054 shares in issue and the average daily traded volume is 61,164 shares. The market capitalisation of Renew Holdings Plc is £632,368,184.70.
rivaldo: Oh yes :o)) Https://uk.advfn.com/stock-market/london/renew-RNWH/share-news/Renew-Holdings-PLC-Trading-Update/85991959 Not just ahead, but "materially" ahead of current market expectations..... Adjusted operating profit is expected to be - at minimum - £50m versus a current consensus forecast of £45.8m. Order books are "strong", and: "Activity levels are supported by long-term regulatory spend and the positive outlook for UK infrastructure. Pleasingly, the integration of the Group's two acquisitions during the period, Browne and REL are proceeding to plan and trading is in line with management's expectations." Great stuff.
rivaldo: In today's IC, Algy Hall has run a screen covering the entire TSE small cap index and AIM to find which companies pass all the stringent tests below to qualify as a "High Quality" share. Only 5 companies passed. RNWH are one of them (MWE, which I also hold, are another): Https://www.investorschronicle.co.uk/ideas/2021/08/26/5-high-quality-aim-shares/ "The full screening criteria: PE ratio above bottom fifth and below top fifth of all stocks screened. A genuine value (GV) ratio below the top quarter of stocks screened. GV ratio = (enterprise value/operating profit)/(forecast EPS growth + dividend yield) Earnings growth forecast in each of the next two financial years. Interest cover of five times or more. Positive free cash flow. Market capitalisation over £20m. A top-quarter return on equity (RoE) in each of the past three years. A top-quarter operating margin in each of the past three years. Operating profit growth over the past three years"
rivaldo: July's issue of SCSW is now out, so it should be OK to copy the Buy recommendation for RNWH from the prior issue in June FYI: "Renew Holdings Epic code: RNWH (Sharewatch) Renew has reported an excellent H1 to end March (against comparatives that were pre-Covid), with sales up 17% to £366m, pretax profit up 19% to £18.1m and eps up 14% at 22.9p. Adjusted operating profit margin was 6% (down from 6.4%) mainly due to a mix change - with a higher proportion of speciality building work, which is only 2% margin. Helped by six months from Carnell (versus three) Engineering Services grew sales 12% to £327m (+6.6% organic) with operating profit up from £20.5m to £22m. This was driven pretty much singlehandedly by a strong period in Rail. Divisional work tends to be underpinned by frameworks but H1 saw weakness in Nuclear where all non essential work was stopped during the pandemic but this has since resumed to 85% of pre-pandemic levels. Water also saw a bit of a hiatus in work as the sector transitions from AMP6 to AMP7. But Renew is well versed to these cyclical changes. CEO Paul Scott tells me he expects growth in the middle part of the five-year cycle to resume and is now working with nine of the 26 UK water companies. Post period end it bought J Browne, a water focussed engineering services business, which works for Thames, South Eastern and South Water. Given that Thames has such complexity, it was a region that would have been hard to enter organically. Net debt post the deal is £16m. Trading in the first few weeks of H2 has been strong aided by the record period-end order book (£665m in engineering services) and margins look set to recover as H2 will be lapping weak covid impacted months. Peel Hunt forecasts £44.5m pretax profit/eps 45.6p. Although a ten-bagger on the first write up, the shares still look a Buy."
doubleorquits: Hi Mayers, Like CWA1, as an executor of a will I have used RNWH amongst a few other AIM shares to eliminate an IHT bill 3 years ago. I presented all the information required on a spreadsheet with transactions listed and copies of contracts. I had no feedback except a tax free experience so I can only assume that it was successful! There was no evidence that any of the shares did not qualify but then that is the level of the lack of information and transparency I have grown to expect from these sorts of things. This perk inevitably helps make RNWH attractive as an investment but I think the fundamentals and reliability of the results from the company YoY are a much greater attraction and for me, at least, far outweigh everything (been holding a long, long time myself as well!)
rivaldo: Nice £5k buy at 787p just now....looks like the 117,000 shares at 770p earlier were buys given the subsequent share price movement.
bsdjj: Consensus EPS forecasts on Eikon are 46.13p for 2021, 51.73p for 2022 and 53.61p for 2023.That puts stock on P/E of 14.3 times 2023 expected earnings. Hardly expensive even after the share price rise for a growing business in a defensive sector.I also suspect that the share price is also indicating that those consensus forecasts will be revised upwards in due course.
cfb2: Over the past few years I've considered RNWH undervalued. They've been steadily winning contracts but the share price hasn't really moved. It's taken a long time for the market to realise, I wonder what the catalyst for a reassessment was.
rivaldo: I've held mine since a two-digit share price (probably 2012 or so from memory), so not far from a 10-year anniversary! I'm still holding all my shares and will continue to do so. There are years and years of solid - and increasing - growth on the cards in all of RNWH's core sectors. Plus with most of RNWH's revenues being non-discretionary, driven by regulation and guaranteed by the need for continual maintenance and improvements RNWH has excellent defensive qualities as well as growth prospects.
rivaldo: RNWH have been tipped by Andrew Hore on i.i.i as an AIM stock suitable for ISAs concentrating on inheritance tax reducing stocks: Https://www.ii.co.uk/analysis-commentary/aim-stocks-inheritance-tax-isa-2021-ii515864 "Renew Holdings Renew Holdings (LSE:RNWH) has focused on providing regular maintenance services for rail, water, nuclear and telecoms. This means that business has held up during the past year. The engineering services order book was worth £583 million at the end of 2020. In the past few weeks, Renew has acquired water infrastructure company J Browne Group for £29.5 million and this is immediately earnings enhancing. The Enfield-based business provides services to water companies and developers, where it provides utility connections. In the year to March 2020, pre-tax profit was £5.5 million, but there has been a reduction in activity this year due to the change in the regulatory period for the water industry. Work will build up as the latest regulatory period progresses. Interim figures will be published on 14 May. The full year pre-tax profit forecast for 2020-21 is £43.2 million and the prospective multiple is 14 – based on a share price of 620p. The forecast yield is 2.2%."
wad collector: Wow , who would have suspected the news of one vaccine preliminary results would be so dramatic on the markets? Untested in the vulnerable groups, no information on mortality reduction, major logistic problems with distribution of a thermally unstable RNA compound are just some of the problems , but hope is driving the markets up. If you are not in the at-risk groups don't hold your breath , you won't be getting a covid immunisation pair of appointments soon! But at least it is taking the RNWH share price back up to where we mostly agree it ought to be.
Renew share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210920 15:35:54